Literature DB >> 26038203

The genetics of adrenocortical tumors.

Stéphanie Espiard1, Jérôme Bertherat2.   

Abstract

Advances in genomics accelerated greatly progress in the study of the genetics adrenocortical tumors. Bilateral nodular hyperplasias causing Cushing's syndrome are frequently caused by germline alterations leading to cAMP/PKA pathway activation (micronodular) and ARMC5 inactivation (macronodular). Somatic mutations of β-catenin and PRKACA are observed in non secreting or cortisol producing adenomas, respectively. Alterations of the β-catenin (CTNN1B, ZNFR3) or TP53 pathways are found in carcinomas. Mutations in cancers are more common in aggressive tumors and correlate with transcriptome or methylation profiles. Identification of these alterations helps to refine the molecular classification of these tumors and to develop molecular diagnostic tools.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARMC5; Adrenal cortex; Cancer; Cushing syndrome; IGF2; PKA; TP53; Wnt/β-catenin

Mesh:

Substances:

Year:  2015        PMID: 26038203     DOI: 10.1016/j.ecl.2015.02.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  9 in total

Review 1.  AKAP Signaling Islands: Venues for Precision Pharmacology.

Authors:  Mitchell H Omar; John D Scott
Journal:  Trends Pharmacol Sci       Date:  2020-10-17       Impact factor: 14.819

Review 2.  Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology.

Authors:  Rigney E Turnham; John D Scott
Journal:  Gene       Date:  2015-12-12       Impact factor: 3.688

3.  Activating PRKACB somatic mutation in cortisol-producing adenomas.

Authors:  Stéphanie Espiard; Matthias J Knape; Kerstin Bathon; Guillaume Assié; Marthe Rizk-Rabin; Simon Faillot; Windy Luscap-Rondof; Daniel Abid; Laurence Guignat; Davide Calebiro; Friedrich W Herberg; Constantine A Stratakis; Jérôme Bertherat
Journal:  JCI Insight       Date:  2018-04-19

Review 4.  Adrenocortical carcinoma: Pediatric aspects (Review).

Authors:  Florica Sandru; Răzvan-Cosmin Petca; Mara Carsote; Aida Petca; Mihai Cristian Dumitrascu; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2022-02-16       Impact factor: 2.447

Review 5.  The role of microRNAs in the adrenocortical carcinomas.

Authors:  Xin Yu; Zheng Li
Journal:  Tumour Biol       Date:  2015-12-15

6.  Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival.

Authors:  Rajani Maharjan; Samuel Backman; Tobias Åkerström; Per Hellman; Peyman Björklund
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

7.  Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma.

Authors:  Vania Balderrama Brondani; Amanda Meneses Ferreira Lacombe; Beatriz Marinho de Paula Mariani; Luciana Montenegro; Iberê Cauduro Soares; João Evangelista Bezerra-Neto; Fabio Yoshiaki Tanno; Victor Srougi; José Luis Chambo; Berenice Bilharinho Mendonca; Madson Q Almeida; Maria Claudia Nogueira Zerbini; Maria Candida Barisson Villares Fragoso
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

Review 8.  Disorders of the adrenal cortex: Genetic and molecular aspects.

Authors:  Georgia Pitsava; Andrea G Maria; Fabio R Faucz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

9.  The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms.

Authors:  Anna Angelousi; Georgios Kyriakopoulos; Fani Athanasouli; Anastasia Dimitriadi; Eva Kassi; Chrysanthi Aggeli; George Zografos; Gregory Kaltsas
Journal:  J Pers Med       Date:  2021-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.